WO2006063703A8 - Polymorphisme a simple nucleotide (snp) - Google Patents
Polymorphisme a simple nucleotide (snp)Info
- Publication number
- WO2006063703A8 WO2006063703A8 PCT/EP2005/012986 EP2005012986W WO2006063703A8 WO 2006063703 A8 WO2006063703 A8 WO 2006063703A8 EP 2005012986 W EP2005012986 W EP 2005012986W WO 2006063703 A8 WO2006063703 A8 WO 2006063703A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diabetes
- type
- single nucleotide
- snp
- nucleotide polymorphism
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- Obesity (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007544791A JP2008522597A (ja) | 2004-12-13 | 2005-12-05 | Ii型糖尿病に関連する単一ヌクレオチド多型(snp) |
EP05823148A EP1828417A2 (fr) | 2004-12-13 | 2005-12-05 | Polymorphisme a simple nucleotide (snp) associes au diabete sucre de type 2 |
CA002589037A CA2589037A1 (fr) | 2004-12-13 | 2005-12-05 | Polymorphisme a simple nucleotide (snp) |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63556304P | 2004-12-13 | 2004-12-13 | |
US60/635,563 | 2004-12-13 | ||
US71432105P | 2005-09-06 | 2005-09-06 | |
US60/714,321 | 2005-09-06 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2006063703A2 WO2006063703A2 (fr) | 2006-06-22 |
WO2006063703A3 WO2006063703A3 (fr) | 2006-10-26 |
WO2006063703A8 true WO2006063703A8 (fr) | 2007-11-08 |
Family
ID=35799724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/012986 WO2006063703A2 (fr) | 2004-12-13 | 2005-12-05 | Polymorphisme a simple nucleotide (snp) |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1828417A2 (fr) |
JP (1) | JP2008522597A (fr) |
CA (1) | CA2589037A1 (fr) |
WO (1) | WO2006063703A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2102368A1 (fr) * | 2007-01-19 | 2009-09-23 | Integragen | Gène btbd9 de susceptibilité au diabète humain |
US20110129820A1 (en) * | 2007-04-10 | 2011-06-02 | Integragen | Human diabetes susceptibility tnfrsf10b gene |
WO2008122673A2 (fr) * | 2007-04-10 | 2008-10-16 | Integragen | Gène tnfrsf10a de susceptibilité au diabète chez l'homme |
EP2134867A1 (fr) * | 2007-04-10 | 2009-12-23 | Integragen | Gène tnfrsf10c de susceptibilité au diabète chez l'homme |
WO2008122672A1 (fr) * | 2007-04-10 | 2008-10-16 | Integragen | Gène tnfrsf10d de susceptibilité au diabète chez l'homme |
EP2145020A2 (fr) * | 2007-05-04 | 2010-01-20 | Integragen | Gène eefsec humain de prédisposition au diabète |
CN103882127B (zh) * | 2014-03-13 | 2016-03-16 | 河北联合大学 | 用于预测患2型糖尿病肾病发生风险的试剂盒 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5863724A (en) * | 1994-04-13 | 1999-01-26 | Baylor College Of Medicine | Methods of screening for persistent hyperinsulinemic hypoglycemia of infancy |
US6783942B2 (en) * | 1998-10-08 | 2004-08-31 | Uab Research Foundation | Isolated polynucleotide associated with type II diabetes mellitus and methods of use thereof |
EP1348031A2 (fr) * | 2000-12-27 | 2003-10-01 | Riken | Detection de polymorphismes genetiques dans des genes associes avec pharmacogenomiques |
WO2004084797A2 (fr) * | 2003-02-28 | 2004-10-07 | Hubit Genomix Inc | Gene associe au diabete sucre du type 2 et son utilisation |
-
2005
- 2005-12-05 JP JP2007544791A patent/JP2008522597A/ja active Pending
- 2005-12-05 EP EP05823148A patent/EP1828417A2/fr not_active Withdrawn
- 2005-12-05 WO PCT/EP2005/012986 patent/WO2006063703A2/fr active Application Filing
- 2005-12-05 CA CA002589037A patent/CA2589037A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2008522597A (ja) | 2008-07-03 |
EP1828417A2 (fr) | 2007-09-05 |
WO2006063703A3 (fr) | 2006-10-26 |
WO2006063703A2 (fr) | 2006-06-22 |
CA2589037A1 (fr) | 2006-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006063704A3 (fr) | Polymorphisme a simple nucleotide (snp) | |
WO2006063703A3 (fr) | Polymorphisme a simple nucleotide (snp) | |
WO2003038123A3 (fr) | Procede de traitement du diabete et conditions apparentees basees sur des polymorphismes dans le gene tcf1 | |
WO2006119775A3 (fr) | Procede de diagnostic et de traitement d'une maladie mentale | |
WO2009059317A3 (fr) | Prédiction d'amd avec snps à l'intérieur ou près de c2, facteur b, plekha1, htra1, prelp ou loc387715 | |
WO2008151803A3 (fr) | Nouveaux polymorphismes du gène abcb1 associés à une absence de réaction clinique à des médicaments | |
WO2008017002A3 (fr) | Polymorphismes dans des gènes affectant des troubles du système nerveux central et leurs utilisations | |
WO2006023719A3 (fr) | Mutation genetique indiquant un risque accru de schizophrenie, de trouble schizo-affectif et de trouble bipolaire et applications pour le diagnostic et le traitement de ces maladies | |
WO2007025085A8 (fr) | Carte genetique de genes humains associes a la maladie de crohn | |
SG142154A1 (en) | Methods for genomic analysis | |
EP2453024A3 (fr) | Gènes et voies exprimés différemment dans le trouble bipolaire et/ou le trouble dépressif majeur | |
WO2008147887A8 (fr) | Méthodes et trousses permettant de lier des séquences polymorphes à des mutations à répétions étendues | |
WO2008137762A3 (fr) | Procédés de diagnostic et de traitement de la maladie de crohn | |
WO2007149798A3 (fr) | Biomarqueurs pour la progression de la maladie d'alzheimer | |
SI1730315T1 (sl) | Polimorfizmi v genu NOD2/CARD15 | |
WO2005072151A3 (fr) | Marqueurs genetiques apoe associes a l'age de l'apparition de la maladie d'alzheimer | |
WO2009036100A3 (fr) | Prédiction de la prolongation du qt en fonction du génotype snp | |
WO2006028999A3 (fr) | Evaluation de polymorphismes ctla-4 dans une therapie de blocage de ctla-4 | |
WO2006099259A3 (fr) | Nouvelles mutations faux-sens et polymorphismes a simple nucleotide dans le gene du type rabphillin-3a et utilisations correspondantes | |
WO2007006862A3 (fr) | Methode et trousse permettant de detecter un risque de coronaropathie | |
WO2003070082A3 (fr) | Utilisation de polymorphismes de nucleotides simples dans le locus comt et dans les loci voisins pour determiner une predisposition a la schizophrenie, au trouble bipolaire, au cancer du sein et au cancer colorectal | |
WO2003054166A3 (fr) | Polymorphisme nucleotidiques associes a l'osteoarthrite | |
WO2006053955A3 (fr) | Procede et kit de detection d'un risque d'hypertension arterielle essentielle | |
WO2005072152A3 (fr) | Marqueurs genetiques apoc1 associes a la periode d'apparition de la maladie d'alzheimer | |
WO2008065544A3 (fr) | Prédicteurs génétiques d'un risque de diabète sucré de type 2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005823148 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2589037 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007544791 Country of ref document: JP |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580048008.4 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2005823148 Country of ref document: EP |